A somatostatin szerepe a felsó tápcsatornai vérzések kezelésében.

Translated title of the contribution: Role of somatostatin in the management of upper gastrointestinal bleeding

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

There exists a substantial basis of experimental and clinical data to support that somatostatin and its long acting synthetic analogue octreotide may be therapeutically efficacious either as primary or adjunctive therapy in subgroups of patients with upper gastrointestinal bleeding. It has been proposed that somatostatin represents the optimal drug treatment for acute variceal bleeding due to its efficacy, its simplicity of administration and its lack of significant side effects. It provides beneficial respite if endoscopic therapy cannot be performed immediately. Somatostatin also facilitates the performance of diagnostic and of non-pharmaceutic interventions. Despite strong theoretical evidence in support of the application of somatostatin to the control of acute nonvariceal gastrointestinal bleeding, clinical trials have yielded conflicting results.

Translated title of the contributionRole of somatostatin in the management of upper gastrointestinal bleeding
Original languageHungarian
Pages (from-to)1092-1099
Number of pages8
JournalOrvosi hetilap
Volume143
Issue number19 Suppl
Publication statusPublished - May 12 2002

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Role of somatostatin in the management of upper gastrointestinal bleeding'. Together they form a unique fingerprint.

  • Cite this